Clinical Trials for KalVista Pharmaceuticals

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: KalVista Pharmaceuticals

Clinical Trials (4)

NCT07009262
A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks
N/ARecruiting
50 participants
Started: Apr 21, 2025 · Completed: Apr 7, 2026
1 condition2 sponsors1 location
NCT06467084
Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II
PHASE3Recruiting
48 participants
Started: Jun 24, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor24 locations
NCT05505916
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)
PHASE3Active, not recruiting
145 participants
Started: Oct 24, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor71 locations
NCT05511922
PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial
PHASE3Active, not recruiting
11 participants
Started: Oct 24, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor61 locations